Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-036054

EVP, Chief Medical Officer sold 2,042 shares at $17.04 ($34,792)

From the SEC's structured data for this filing

Trades in this filing

Eisner Mark · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Sale : show line 1 in the form −2,042 $17.04 $34,792 162,862 D
Open-market sales · 2,042 sh · avg $17.04 · $34,792
Loading xslF345X04/doc4.xml…